Literature DB >> 17625593

Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases.

Kristina Stefansson1, Maria Brattsand, Dirk Roosterman, Cordula Kempkes, Georgeta Bocheva, Martin Steinhoff, Torbjörn Egelrud.   

Abstract

Proteinase-activated receptor-2 (PAR2) is a seven transmembrane spanning, G-protein-coupled receptor, present on the membrane of many cell types including keratinocytes. In skin, PAR2 is suggested to play a regulatory role during inflammation, epidermal barrier function, and pruritus. PAR2 is activated by trypsin-like proteases by a unique mechanism where cleavage of the receptor leads to the release of a small peptide, which activates the receptor as a tethered ligand. The endogenous activators of PAR2 on keratinocytes have not been identified as of yet. Potential candidates are kallikrein-related peptidases (KLKs) expressed by epidermal cells. Therefore, the ability of four human skin-derived KLKs was examined with regard to their capacity to activate PAR2 in vitro. PAR2 cleavage was followed by immunofluorescence analysis and functional activation by measurements of changes in intracellular calcium levels. We found that KLK5 and KLK14, but neither KLK7 nor KLK8, induced PAR2 signalling. We conclude that certain, but not all, epidermal KLKs are capable of activating PAR2. We could also show the coexpression of KLK14 and PAR2 receptor in inflammatory skin disorders. These in vitro results suggest that KLKs may take part in PAR2 activation in the epidermis and thereby in PAR2-mediated inflammatory responses, including epidermal barrier repair and pruritus. The role of KLKs in PAR2 activation in vivo remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625593     DOI: 10.1038/sj.jid.5700965

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  53 in total

Review 1.  Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.

Authors:  Akiharu Kubo; Keisuke Nagao; Masayuki Amagai
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

Review 2.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

3.  Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis.

Authors:  Peter M Elias
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 4.  "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

Authors:  Peter M Elias; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2008-05       Impact factor: 8.551

5.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

6.  Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins.

Authors:  Karolina Plaza; Magdalena Kalinska; Oliwia Bochenska; Ulf Meyer-Hoffert; Zhihong Wu; Jan Fischer; Katherine Falkowski; Laura Sasiadek; Ewa Bielecka; Barbara Potempa; Andrzej Kozik; Jan Potempa; Tomasz Kantyka
Journal:  J Biol Chem       Date:  2016-06-27       Impact factor: 5.157

Review 7.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

8.  PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.

Authors:  Travis P Barr; Chris Garzia; Srijoy Guha; Elizabeth K Fletcher; Nga Nguyen; Adam J Wieschhaus; Lluis Ferrer; Lidija Covic; Athan Kuliopulos
Journal:  J Invest Dermatol       Date:  2018-10-01       Impact factor: 8.551

9.  Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

Authors:  Valérie Gratio; Nathalie Beaufort; Lina Seiz; Josefine Maier; G Duke Virca; Mekdes Debela; Nicolai Grebenchtchikov; Viktor Magdolen; Dalila Darmoul
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

Review 10.  Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis.

Authors:  Sang Eun Lee; Se Kyoo Jeong; Seung Hun Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.